We are live on ! Find out more
SCM

Smead Capital Management Portfolio holdings

AUM $4.6B
1-Year Est. Return 27.56%
This Fund
S&P 500
This Quarter Est. Return
+8.43%
1 Year Est. Return
+27.56%
3 Year Est. Return
+64.97%
5 Year Est. Return
+125.46%
10 Year Est. Return
+462.58%
AUM
$726M
AUM Growth
+$109M
Cap. Flow
+$52.6M
Cap. Flow %
7.25%
Top 10 Hldgs %
52.16%
Holding
30
New
1
Increased
24
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
NVR icon
NVR
NVR
+$14.1M
2
MRK icon
Merck
MRK
+$9.19M
3
TGNA
TEGNA Inc
TGNA
+$3.63M
4
WBA
Walgreens Boots Alliance
WBA
+$3.15M
5
EBAY icon
eBay
EBAY
+$3.15M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$11.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$5.37M
3
VTRS icon
Viatris
VTRS
+$2.04M

Sector Composition

Rank Sector Weight
1 Healthcare 35.2%
2 Financials 25.63%
3 Consumer Discretionary 20.56%
4 Communication Services 11.87%
5 Technology 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGNA
1
DELISTED
TEGNA Inc
TGNA
$49.8M 6.86%
3,220,352
+257,402
+9% +$3.63M
CAB
2
DELISTED
Cabela's Inc
CAB
$41.5M 5.72%
623,327
+49,436
+9% +$3.07M
EBAY icon
3
eBay
EBAY
$48.6B
$41.1M 5.66%
1,778,783
+142,125
+9% +$3.15M
WBA
4
DELISTED
Walgreens Boots Alliance
WBA
$38.9M 5.36%
677,673
+54,103
+9% +$3.15M
DIS icon
5
Walt Disney
DIS
$165B
$36.4M 5.01%
475,809
+37,223
+8% +$2.58M
AFL icon
6
Aflac
AFL
$63.9B
$36M 4.95%
1,076,896
+86,320
+9% +$2.83M
BAC icon
7
Bank of America
BAC
$435B
$35.4M 4.88%
2,273,789
+183,991
+9% +$2.73M
AMGN icon
8
Amgen
AMGN
$203B
$34.2M 4.71%
299,539
+24,091
+9% +$2.74M
MRK icon
9
Merck
MRK
$324B
$33.2M 4.57%
694,524
+201,008
+41% +$9.19M
JPM icon
10
JPMorgan Chase
JPM
$939B
$32.3M 4.45%
552,407
+44,611
+9% +$2.44M
WFC icon
11
Wells Fargo
WFC
$261B
$31.1M 4.28%
684,586
+54,311
+9% +$2.35M
CMCSK
12
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$26.9M 3.71%
539,952
+42,951
+9% +$2.14M
JWN
13
DELISTED
Nordstrom
JWN
$26.5M 3.64%
428,067
+33,991
+9% +$2.05M
BEN icon
14
Franklin Resources
BEN
$16.9B
$26.2M 3.6%
453,336
+35,820
+9% +$1.93M
BRK.B icon
15
Berkshire Hathaway Class B
BRK.B
$1.07T
$24M 3.31%
202,747
+15,977
+9% +$1.85M
PFE icon
16
Pfizer
PFE
$140B
$23.1M 3.18%
794,821
+63,376
+9% +$1.84M
ACN icon
17
Accenture
ACN
$89.9B
$22.1M 3.04%
268,791
+21,147
+9% +$1.6M
HRB icon
18
H&R Block
HRB
$5.18B
$21.9M 3.02%
754,328
+60,462
+9% +$1.72M
HD icon
19
Home Depot
HD
$332B
$21.6M 2.98%
262,388
+21,187
+9% +$1.65M
VTRS icon
20
Viatris
VTRS
$20.1B
$17.9M 2.47%
412,814
-49,708
-11% -$2.04M
MDT icon
21
Medtronic
MDT
$107B
$17.1M 2.36%
298,115
+23,694
+9% +$1.34M
NVR icon
22
NVR
NVR
$17.2B
$15.2M 2.09%
+14,805
New +$14.1M
ABBV icon
23
AbbVie
ABBV
$458B
$15M 2.07%
284,630
+22,673
+9% +$1.11M
JNJ icon
24
Johnson & Johnson
JNJ
$635B
$13.4M 1.85%
146,458
+11,682
+9% +$1.08M
MCD icon
25
McDonald's
MCD
$188B
$12.3M 1.69%
126,816
+10,119
+9% +$972K

Similar funds

Smead Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Smead Capital Management held 30 positions worth $726M, up 18% from $617M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Smead Capital Management deployed $52.6M of net new capital in Q4 2013, opening 1 new position and adding to 24 existing holdings. Its largest new stake was NVR: 14,805 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 36% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Starbucks, an estimated $11.7M trimmed.

  • Smead Capital Management's largest Q4 2013 buy was NVR: 14,805 shares worth $15.2M.
  • Smead Capital Management added most to Merck in Q4 2013, an estimated $9.19M increase.
  • Smead Capital Management's biggest Q4 2013 reduction was Starbucks, cutting an estimated $11.7M.
  • Smead Capital Management's ten largest holdings make up 52% of its $726M portfolio in Q4 2013.
  • Smead Capital Management opened 1 new position and closed 1 in Q4 2013.
  • Smead Capital Management's portfolio value rose 18% quarter-over-quarter to $726M.

Based on Smead Capital Management's 13F filing for Q4 2013, filed 7 Feb 2014.